Scott Eblen to Ubiquitin-Protein Ligases
This is a "connection" page, showing publications Scott Eblen has written about Ubiquitin-Protein Ligases.
Connection Strength
1.026
-
EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer. Carcinogenesis. 2014 May; 35(5):1100-9.
Score: 0.436
-
Identification of phosphorylation sites on the E3 ubiquitin ligase UBR5/EDD. J Proteomics. 2011 Dec 21; 75(2):603-9.
Score: 0.371
-
Identification of novel ERK2 substrates through use of an engineered kinase and ATP analogs. J Biol Chem. 2003 Apr 25; 278(17):14926-35.
Score: 0.205
-
Identifying specific kinase substrates through engineered kinases and ATP analogs. Methods. 2004 Apr; 32(4):389-97.
Score: 0.014